Adline Chem Lab MD, chairman, board of directors and AGM
BSE: 524604Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 12 Oct 2026. Previous close ₹15.79.
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.24 Cr4,835th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −685.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,500
Adline Chem Lab board of directors
At the end of the quarter to Sep 2018, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonMahendra Popatlal Shah
6 directors2 independent3 executive1 non-executive
- Kamlesh Jagdish LaskariExecutive · joined Dec 2017 · 1 listed board · 1 committee seat
- Rohan Kamlesh LaskariExecutive · joined Aug 2018 · 1 listed board
- Sohan Kamlesh LaskariExecutive · joined Aug 2018 · 1 listed board
- Ranak Kamlesh LaskariNon-executive · joined Jul 1988 · 1 listed board · 1 committee seat, 1 as chair
- Mahendra Popatlal Shah · ChairpersonIndependent · joined Sep 2014 · 60 months as independent · 1 listed board
- Devarshi Dilipbhai PatelIndependent · joined Sep 2015 · 60 months as independent · 1 listed board · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 14 Aug 201824 days in between
- 20 Jul 201851 days in between
- 29 May 2018
Audit Committee
- 14 Aug 201876 days in between
Nomination and remuneration committee
- 20 Jul 2018
Stakeholders Relationship Committee
- 14 Aug 201876 days in between
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Adline Chem Lab AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Adline Chem Lab share news and announcements
Annual general meeting, 28 Sep 2026
18,451 shareholders on the register on 21 Sep 2026; present: 0 promoters and 33 others; votes counted by Ishit Vyas / Ishit Vyas & Co.The company's voting result (opens in a new tab)
Adoption of Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Statement of Assets and Liabilities, the Statement of Cash Flows, and the comprehensive Reports of the Board of Directors and the Independent Statutory Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 26.11% · promoters 99.97% · institutions 0.00% · other public 0.36%
- Appointment of Statutory Auditor for a term of 5 (five) consecutive yearsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 26.11% · promoters 99.97% · institutions 0.00% · other public 0.36%
- Approval for the appointment of Statutory Auditor to fill the Casual VacancyOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.64%
Turnout: all 26.11% · promoters 99.97% · institutions 0.00% · other public 0.36%
- To approve regularization of Additional Director Mrs. Anita Ganeshbhai Marvadi (DIN: 11808366) as Non-Executive Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 26.12% · promoters 100.00% · institutions 0.00% · other public 0.36%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Compliance
- The board is made up as the listing rules require
- Yes
- The company has a risk management committee
- No
The company's own answers in its filing.